Gene expression analysis in breast cancer. A new diagnostic tool in pathology

被引：0

作者：

Denkert, C. ^{[1
]}

机构：

[1] Charite, Inst Pathol, D-10117 Berlin, Germany

来源：

PATHOLOGE | 2013年 / 34卷 / 05期

关键词：

Molecular biomarkers; Prognosis; Chemotherapy; Molecular diagnostics; EndoPredict; CLINICAL-ONCOLOGY-COLLEGE; PARAFFIN-EMBEDDED TISSUE; GUIDELINE RECOMMENDATIONS; ESTROGEN-RECEPTOR; AMERICAN-SOCIETY; ANALYTICAL VALIDATION; HER2; STATUS; RECURRENCE; PROGNOSIS; RNA;

D O I：

10.1007/s00292-013-1781-2

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Molecular biomarker analysis is increasingly being used as a basis for individualized therapy selection. In breast cancer established standard biomarkers are hormone receptors, HER2 and if indicated Ki67. In particular for hormone receptor positive, HER2 negative tumors, gene expression analysis provides additional information on proliferation and hormone receptor signalling. The results of the gene expression tests can be used to identify patients with a very good prognosis under an exclusive endocrine therapy. This group of patients can then be treated without conventional chemotherapy. The EndoPredict assay was validated in two large cohorts from clinical studies of the Austrian breast cancer study group (ABCSG). Furthermore, using a round robin test, the test method was established in several German institutes of molecular pathology. The EndoPredict assay can be carried out in local institutes of pathology and offers additional information to existing standard prognostic parameters.

引用

页码：413 / 418

页数：6

共 28 条

[11] A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors [J].

Filipits, Martin ;

Rudas, Margaretha ;

Jakesz, Raimund ;

Dubsky, Peter ;

Fitzal, Florian ;

Singer, Christian F. ;

Dietze, Otto ;

Greil, Richard ;

Jelen, Andrea ;

Sevelda, Paul ;

Freibauer, Christa ;

Mueller, Volkmar ;

Jaenicke, Fritz ;

Schmidt, Marcus ;

Koelbl, Heinz ;

Rody, Achim ;

Kaufmann, Manfred ;

Schroth, Werner ;

Brauch, Hiltrud ;

Schwab, Matthias ;

Fritz, Peter ;

Weber, Karsten E. ;

Feder, Inke S. ;

Hennig, Guido ;

Kronenwett, Ralf ;

Gehrmann, Mathias ;

Gnant, Michael .

CLINICAL CANCER RESEARCH, 2011, 17 (18) :6012-6020

[12] Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 [J].

Goldhirsch, A. ;

Wood, W. C. ;

Coates, A. S. ;

Gelber, R. D. ;

Thuerlimann, B. ;

Senn, H. -J. .

ANNALS OF ONCOLOGY, 2011, 22 (08) :1736-1747

[13] Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement [J].

Guiu, S. ;

Michiels, S. ;

Andre, F. ;

Cortes, J. ;

Denkert, C. ;

Di Leo, A. ;

Hennessy, B. T. ;

Sorlie, T. ;

Sotiriou, C. ;

Turner, N. ;

Van de Vijver, M. ;

Viale, G. ;

Loi, S. ;

Reis-Filho, J. S. .

ANNALS OF ONCOLOGY, 2012, 23 (12) :2997-3006

[14] Clinical Notice for American Society of Clinical Oncology-College of American Pathologists Guideline Recommendations on ER/PgR and HER2 Testing in Breast Cancer [J].

Hammond, M. Elizabeth ;

Hayes, Daniel F. ;

Wolff, Antonio C. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) :E458-E458

[15]

Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48

[16] Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test [J].

Kronenwett, Ralf ;

Bohmann, Kerstin ;

Prinzler, Judith ;

Sinn, Bruno V. ;

Haufe, Franziska ;

Roth, Claudia ;

Averdick, Manuela ;

Ropers, Tanja ;

Windbergs, Claudia ;

Brase, Jan C. ;

Weber, Karsten E. ;

Fisch, Karin ;

Mueller, Berit M. ;

Schmidt, Marcus ;

Filipits, Martin ;

Dubsky, Peter ;

Petry, Christoph ;

Dietel, Manfred ;

Denkert, Carsten .

BMC CANCER, 2012, 12

[17]

MARTIN M, 2012, 2012 SAN ANT BREAST

[18] Quantitative Determination of Estrogen Receptor, Progesterone Receptor, and HER2 mRNA in Formalin-fixed Paraffin-embedded Tissue-A New Option for Predictive Biomarker Assessment in Breast Cancer [J].

Mueller, Berit Maria ;

Kronenwett, Ralf ;

Hennig, Guido ;

Euting, Heike ;

Weber, Karsten ;

Bohmann, Kerstin ;

Weichert, Wilko ;

Altmann, Gabriela ;

Roth, Claudia ;

Winzer, Klaus-Juergen ;

Kristiansen, Glen ;

Petry, Christoph ;

Dietel, Manfred ;

Denkert, Carsten .

DIAGNOSTIC MOLECULAR PATHOLOGY, 2011, 20 (01) :1-10

[19] A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer [J].

Nielsen, Torsten O. ;

Parker, Joel S. ;

Leung, Samuel ;

Voduc, David ;

Ebbert, Mark ;

Vickery, Tammi ;

Davies, Sherri R. ;

Snider, Jacqueline ;

Stijleman, Inge J. ;

Reed, Jerry ;

Cheang, Maggie C. U. ;

Mardis, Elaine R. ;

Perou, Charles M. ;

Bernard, Philip S. ;

Ellis, Matthew J. .

CLINICAL CANCER RESEARCH, 2010, 16 (21) :5222-5232

[20] A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer [J].

Paik, S ;

Shak, S ;

Tang, G ;

Kim, C ;

Baker, J ;

Cronin, M ;

Baehner, FL ;

Walker, MG ;

Watson, D ;

Park, T ;

Hiller, W ;

Fisher, ER ;

Wickerham, DL ;

Bryant, J ;

Wolmark, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2817-2826

← 1 2 3 →